## Abstract Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism (DATATOP) and Parkinson Research Examination of CEPโ1347 Trial (PRECEPT) were two clinical trials of potential diseaseโmodifying agents for Parkinson's disease that used the time to reaching disability sufficient to require d
Comparison of enrollees and decliners of Parkinson disease sham surgery trials
โ Scribed by Scott Y.H. Kim; Renee M. Wilson; H. Myra Kim; Robert G. Holloway; Raymond G. De Vries; Samuel A. Frank; Karl Kieburtz
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 751 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Concerns have been raised that persons with serious illnesses participating in highโrisk research, such as PD patients in sham surgery trials, have unrealistic expectations and are vulnerable to exploitation. A comparison of enrollees and decliners of such research may provide insights about the adequacy of decision making by potential subjects. We compared 61 enrollees and 10 decliners of two phase II neurosurgical intervention (i.e., cellular and gene transfer) trials for PD regarding their demographic and clinical status, perceptions and attitudes regarding research risks, potential direct benefit, and societal benefit, and perspectives on the various potential reasons for and against participation. In addition to bivariate analyses, a logistic regression model examined variables regarding risks and benefits as predictors of participation status. Enrollees perceived lower risk of harm while tolerating higher risk of harm and were more action oriented, but did not have more advanced disease. Both groups rated hope for benefit as a strong reason to participate, whereas the fact that the study's purpose was not solely to benefit them was rated as โnot a reasonโ against participation. Hope for benefit and altruism were rated higher than expectation of benefit as reasons in favor of participation for both groups. Enrollees and decliners are different in their views and attitudes toward risk. Although both are attracted to research because of hopes of personal benefit, this hope is clearly distinguishable from an expectation of benefit and does not imply a failure to understand the main purpose of research. ยฉ 2012 Movement Disorder Society
๐ SIMILAR VOLUMES
## Abstract Parkinson's disease (PD) is a common neurodegenerative disease affecting up to 1 million individuals in the United States. Sleep disturbances, typically in sleep maintenance, are found in up to 88% of these individuals and are associated with a variety of poor outcomes. Despite being co
## Abstract Dysphagia is common in both Parkinson's disease (PD) and progressive supranuclear palsy (PSP). Although it is believed to be more common in PSP, there are no controlled data and no comparison of swallowing function between these two disorders. Our aim was to assess dysphagia and swallow
## Abstract We compared the clinical and neuropsychological pattern of dementia with Lewy bodies (DLB) to Alzheimer's disease (AD) and Parkinson's disease with dementia (PDโd). Sixteen patients clinically diagnosed with DLB were compared with two groups of patients with PDโd (n = 15) and AD (n = 16
## Abstract Background: PREPARED was a randomized, parallelโgroup, doubleโblind, multicenter study to evaluate the efficacy of adjunctive ropinirole prolonged release (PR) versus immediate release (IR) in patients with advanced Parkinson's disease (PD). Methods: Patients received onceโdaily PR (2โ2